Evidence map›Paper›PMID 23495831›Full record

ArticleAntioxidants & redox signaling2013

Antioxidant activity of sestrin 2 controls neuropathic pain after peripheral nerve injury.

Wiebke Kallenborn-Gerhardt, Ruirui Lu, Katharina M J Syhr, Juliana Heidler, Harald von Melchner, Gerd Geisslinger, Thorsten Bangsow, Achim Schmidtko

Abstract read
In one paragraph

Article in Antioxidants & redox signaling, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 64 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. NADPH Oxidases in Pain Processing.Antioxidants (Basel, Switzerland) · 2022
    Review
  11. Sestrin2 in cancer: a foe or a friend?Biomarker research · 2022
    Review
  12. Article
  13. The functions and roles of sestrins in regulating human diseases.Cellular & molecular biology letters · 2022
    Review
  14. Sestrin2 in hypoxia and hypoxia-related diseases.Redox report : communications in free radical research · 2021
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

Wiebke Kallenborn-Gerhardt1 Pharmazentrum Frankfurt/ZAFES, Institute of Clinical Pharmacology, Goethe University Medical School , Frankfurt am Main, Germany .
Ruirui Lu
Katharina M J Syhr
Juliana Heidler
Harald von Melchner
Gerd Geisslinger
Thorsten Bangsow
Achim Schmidtko
Goethe University Frankfurt · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsNeuropathic pain is a chronic debilitating disease that is often unresponsive to currently available treatments. Emerging lines of evidence indicate that reactive oxygen species (ROS) are required for the development and maintenance of neuropathic pain. However, little is known about endogenous mechanisms that neutralize the pain-relevant effects of ROS. In the present study, we tested whether the stress-responsive antioxidant protein Sestrin 2 (Sesn2) blocks the ROS-induced neuropathic pain processing in vivo.

resultsWe observed that Sesn2 mRNA and protein expression was up-regulated in peripheral nerves after spared nerve injury, a well-characterized model of neuropathic pain. Sesn2 knockout (Sesn2(-/-)) mice exhibited considerably increased late-phase neuropathic pain behavior, while their behavior in acute nociceptive and in inflammatory pain models remained unaffected. The exacerbated neuropathic pain behavior of Sesn2(-/-) mice was associated with elevated ROS levels and an enhanced activating transcription factor 3 up-regulation in sensory neurons, and it was reversed by the ROS scavenger N-tert-Butyl-α-phenylnitrone. In contrast, administration of the ROS donor tert-butyl hydroperoxide induced a prolonged pain behavior in naive Sesn2(-/-) mice. INNOVATION: We show that the antioxidant function of Sesn2 limits neuropathic pain processing in vivo.

conclusionSesn2 controls ROS-dependent neuropathic pain signaling after peripheral nerve injury and may, thus, provide a potential new target for the clinical management of chronic neuropathic pain conditions.

Indexed as

Activating Transcription Factor 3AnimalsAntioxidantsFemaleGanglia, SpinalHyperalgesiaInflammationMaleMiceMice, 129 StrainMice, Inbred C57BLMice, KnockoutNeuralgiaNociceptionNuclear ProteinsPeripheral Nerve InjuriesActivating Transcription Factor 3AntioxidantsAtf3 protein, mouseNuclear ProteinsPeroxidasesReactive Oxygen SpeciesSesn2 protein, mouseSestrinsZymosan

Identifiers

PMID23495831
PMCPMC3869453
OpenAlexW2410890185

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.